New Head of Trump’s Cancer Panel Speculated About Links Between Vaccines and Cancer
The article discusses the appointment of Yale epidemiologist Harvey Risch as the new head of the President's Cancer Panel. Risch has previously speculated about a potential link between COVID-19 vaccines and "turbo cancer," and has also promoted the use of ivermectin as a treatment for COVID-19, despite a lack of scientific evidence supporting these claims. The article highlights concerns about Risch's unorthodox views and their potential impact on the work of the President's Cancer Panel, which is tasked with monitoring the National Cancer Program and advising the President on cancer-related issues. While the article notes that Risch's appointment has not been officially confirmed, it raises questions about the credibility and objectivity of the panel under his leadership, given his history of making unsupported claims about vaccine safety and the efficacy of unproven treatments.
Source: For the complete article, please visit the original source link below.
